The Electronics of HER2/neu Positive Breast Cancer Cells

QR Code

The Electronics of HER2/neu Positive Breast Cancer Cells

None

Saved in:

Bibliographic Details
Main Authors:	Baumann, Jan, Karch, Christopher, Kourtidis, Antonis, Conklin, Douglas S.
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2011
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/24947
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

INTRATUMORAL AMPLIFICATION HETEROGENEITY IN HER2/neu-POSITIVE BREAST CANCER MOLECULAR-GENETIC SUBTYPES
by: L. N. Vashchenko, et al.
Published: (2019-11-01)

PIK3CA mutations in breast cancer with low HER2 / neu expression
by: I. A. Pavlenko, et al.
Published: (2022-12-01)

NEW INDICATORS OF HSP27 FUNCTIONAL STATE IN BREAST CANCER CELLS WITH DIFFERENT VARIANTS OF HER2/NEU-STATUS
by: E. V. Kaigorodova, et al.
Published: (2016-02-01)

Possibilities of radionuclide visualization of HER2/neu-positive breast cancer using a radiopharmaceutical based on recombinant targeting molecules DARPin9_29
by: O. D. Bragina, et al.
Published: (2020-08-01)

A case of pathological complete regression in combined modality treatment of resectable Her2/neu-positive gastric cancer
by: A. V. Avgustinovich, et al.
Published: (2024-03-01)

ADJUVANT CHEMOTHERAPY OF PRIMARY OPERABLE LUMINAL B BREAST CANCER WITHOUT OVEREXPRESSION OF HER2/NEU IN POSTMENOPAUSAL WOMEN: YES OR NO?
by: Yu. S. Shatova, et al.
Published: (2017-12-01)

POSSIBILITIES OF THERAPY OF HER-2-POSITIVE REGIONAL BREAST CANCER
by: A. S. Belokhvostova, et al.
Published: (2015-04-01)

Target therapy in treatment of HER2-positive breast cancer
by: A. S. Belokhvostova, et al.
Published: (2016-02-01)

Biological function of long noncoding RNA in HER2-positive breast cancer cells
by: Jeeyeon Lee, et al.
Published: (2017-06-01)

P435 HER2/neu-derived peptide conjugated to liposomes containing DOPE as an effective prophylactic vaccine formulation for breast cancer
by: Niloofar Farzad, et al.
Published: (2019-12-01)

HER-2-positive metastatic breast cancer: new possibilities for therapy
by: E. V. Artamonova, et al.
Published: (2014-07-01)

Beyond HER2-Positive: The ADC Revolution in Breast Cancer Care
by: Marucs Vetter
Published: (2025-06-01)

STUDY OF THE EFFECT OF LOMUSTIN ON HER2-POSITIVE BREAST CANCER IN FVB/N HER-2 TRANSGENIC MICE
by: A. N. Stukov, et al.
Published: (2019-11-01)

Fourth Swiss Annual Meeting on HER2-Positive Breast Cancer: Antibody-Drug Conjugates in HER2-Positive Disease and Beyond
by: Marcus Vetter, et al.
Published: (2025-06-01)

Improving treatment outcomes for patients with HER2‑positive breast cancer using neoadjuvant double HER2 blockade
by: V. F. Semiglazov, et al.
Published: (2024-11-01)

Current approaches to the treatment of HER2‑positive breast cancer with brain metastases
by: T. Yu. Semiglazova, et al.
Published: (2021-06-01)

EXPERIENCE OF USING PERTUZUMAB IN ANTICANCER THERAPY FOR HER2-POSITIVE BREAST CANCER
by: O. I. Kit, et al.
Published: (2021-05-01)

Expression of E- and N-cadherins in tumor in luminal, primary operable breast cancer without Her2/neu overexpression in postmenopausal women as a prognostic factor
by: V. V. Tokmakov, et al.
Published: (2020-12-01)

Multilineal treatment strategy of HER2-positive metastatic breast cancer (clinical case)
by: A. F. Nasretdinov, et al.
Published: (2021-06-01)

Role of targeted therapy in the treatment of HER-2-positive breast cancer brain metastases
by: G. A. Dashyan, et al.
Published: (2016-06-01)

Possibilities of predicting the HER2 / neu status in a primary tumor in breast cancer patients using <sup>99m</sup>Tc-DARPinG3
by: O. D. Bragina, et al.
Published: (2023-01-01)

HER-2 Signaling in Human Breast Cancer
by: Ignatoski, Kathleen M. Woods
Published: (2011)

Clinical possibilities of HER2-positive breast cancer diagnosis using alternative scaffold proteins
by: O. D. Bragina, et al.
Published: (2022-10-01)

Recent Research Advances in HER2-Positive Breast Cancer Concerning Targeted Therapy Drugs
by: Junmin Li, et al.
Published: (2025-07-01)

Emergence of a new me: Experiences of women diagnosed with HER2-positive breast cancer.
by: Josianne Scerri, et al.
Published: (2025-01-01)

Emergence of a new me: Experiences of women diagnosed with HER2-positive breast cancer
by: Josianne Scerri, et al.
Published: (2025-01-01)

EVALUATION OF EXTENT OF BREAST CANCER IN A PATIENT WITH HER2/NEU OVEREXPRESSION USING A RADIOPHARMACEUTICAL BASED ON TECHNETIUM-99M-LABELED TARGET MOLECULES (CASE REPORT)
by: O. D. Bragina, et al.
Published: (2021-10-01)

Immunomorphological specifcity of HER2-low breast cancer
by: I. V. Mikhailov, et al.
Published: (2024-11-01)

A novel bispecific aptamer targeting LAG3 and HER2 enhances T cell-mediated immunotherapy against HER2-positive cancer cells
by: Rui Guo, et al.
Published: (2025-07-01)

Echo-loop of subclinical cardiovascular toxicity in women associated with HER2-positive breast cancer therapy
by: I. V. Pershukov, et al.
Published: (2024-07-01)

A Mathematical Model for Complete Morphological Regression in Primary Operable HER2-Positive Breast Cancer
by: A. E. Orlov, et al.
Published: (2021-04-01)

LONG-LASTING CONTROL OF HER-2 POSITIVE DISSEMINATED BREAST CANCER IN A REPRODUCTIVE AGED PATIENT
by: A. V. Vazhenin, et al.
Published: (2021-06-01)

HORMONE-POSITIVE HER2-NEGATIVE METASTATIC BREAST CANCER: DECISION MAKING IN REAL CLINICAL PRACTICE
by: L. Yu. Vladimirova, et al.
Published: (2020-06-01)

Neu-Guinea /
by: Griker, Maximilian
Published: (1899)

Neu-Guinea /
by: Fuhrmann, Ernst
Published: (1922)

The development of a highly specific radiochemical compound based on labeled 99mtc recombinant molecules for targeted imaging of cells with the overexpression of Her-2 / neu
by: Olga D. Bragina, et al.
Published: (2017-10-01)

PHARMACOECONOMIC EVALUATION OF RIBOCICLIB FOR THE FIRST-LINE TREATMENT OF HR-POSITIVE HER2-NEGATIVE ADVANCED BREAST CANCER
by: N. A. Avksentyev, et al.
Published: (2018-08-01)

Comparison of the efficacy of different dual-targeted combined chemotherapy regimens for treating HER2-positive breast cancer
by: Yu-hua Xia, et al.
Published: (2025-08-01)

Clinical characteristics, treatment, and survival of thrombocytopenia induced by T-DM1 in early HER2-positive breast cancer
by: Fang Wang, et al.
Published: (2025-07-01)

Antibody-functionalized iron-based nanoplatform for ferroptosis-augmented targeted therapy of HER2-positive breast cancer
by: Jingchao Gao, et al.
Published: (2025-10-01)